BR112013027122A2 - método e sistema para analisar características de tecido, e, kit - Google Patents

método e sistema para analisar características de tecido, e, kit

Info

Publication number
BR112013027122A2
BR112013027122A2 BR112013027122A BR112013027122A BR112013027122A2 BR 112013027122 A2 BR112013027122 A2 BR 112013027122A2 BR 112013027122 A BR112013027122 A BR 112013027122A BR 112013027122 A BR112013027122 A BR 112013027122A BR 112013027122 A2 BR112013027122 A2 BR 112013027122A2
Authority
BR
Brazil
Prior art keywords
cell
field
tissue characteristics
assessment
observed
Prior art date
Application number
BR112013027122A
Other languages
English (en)
Portuguese (pt)
Inventor
Christopher James Sevinsky
Colin Craig Mcculloch
Fiona Ginty
Original Assignee
Gen Electric
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Electric filed Critical Gen Electric
Publication of BR112013027122A2 publication Critical patent/BR112013027122A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57555—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F18/00—Pattern recognition
    • G06F18/20—Analysing
    • G06F18/21—Design or setup of recognition systems or techniques; Extraction of features in feature space; Blind source separation
    • G06F18/211—Selection of the most significant subset of features
    • G06F18/2115—Selection of the most significant subset of features by evaluating different subsets according to an optimisation criterion, e.g. class separability, forward selection or backward elimination
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
    • G06V10/00—Arrangements for image or video recognition or understanding
    • G06V10/70—Arrangements for image or video recognition or understanding using pattern recognition or machine learning
    • G06V10/77—Processing image or video features in feature spaces; using data integration or data reduction, e.g. principal component analysis [PCA] or independent component analysis [ICA] or self-organising maps [SOM]; Blind source separation
    • G06V10/771—Feature selection, e.g. selecting representative features from a multi-dimensional feature space
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
    • G06V20/00—Scenes; Scene-specific elements
    • G06V20/60—Type of objects
    • G06V20/69—Microscopic objects, e.g. biological cells or cellular parts
    • G06V20/698—Matching; Classification
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Theoretical Computer Science (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Multimedia (AREA)
  • Artificial Intelligence (AREA)
  • Data Mining & Analysis (AREA)
  • Evolutionary Computation (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Software Systems (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Databases & Information Systems (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Computing Systems (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Image Processing (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
BR112013027122A 2011-04-22 2012-04-23 método e sistema para analisar características de tecido, e, kit BR112013027122A2 (pt)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201161478224P 2011-04-22 2011-04-22
US13/252,080 US20120271553A1 (en) 2011-04-22 2011-10-03 Analyzing the expression of biomarkers in cells with clusters
US13/252,069 US20120270752A1 (en) 2011-04-22 2011-10-03 Analyzing the expression of biomarkers in cells with moments
US13/252,072 US20120269418A1 (en) 2011-04-22 2011-10-03 Analyzing the expression of biomarkers in cells with clusters
US13/252,078 US20120269419A1 (en) 2011-04-22 2011-10-03 Analyzing the expression of biomarkers in cells with moments
PCT/EP2012/057394 WO2012143561A2 (en) 2011-04-22 2012-04-23 Analyzing the expression of biomarkers in cells with clusters

Publications (1)

Publication Number Publication Date
BR112013027122A2 true BR112013027122A2 (pt) 2017-01-10

Family

ID=47021377

Family Applications (4)

Application Number Title Priority Date Filing Date
BR112013027122A BR112013027122A2 (pt) 2011-04-22 2012-04-23 método e sistema para analisar características de tecido, e, kit
BR112013027124A BR112013027124A2 (pt) 2011-04-22 2012-04-23 método e sistema para analisar características de tecido
BR112013027123A BR112013027123A2 (pt) 2011-04-22 2012-04-23 método e sistema para analisar características de tecido, e, método de análise de características de agrupamento de células
BR112013027125A BR112013027125A2 (pt) 2011-04-22 2012-04-23 método e sistema para analisar características de tecido, e, kit

Family Applications After (3)

Application Number Title Priority Date Filing Date
BR112013027124A BR112013027124A2 (pt) 2011-04-22 2012-04-23 método e sistema para analisar características de tecido
BR112013027123A BR112013027123A2 (pt) 2011-04-22 2012-04-23 método e sistema para analisar características de tecido, e, método de análise de características de agrupamento de células
BR112013027125A BR112013027125A2 (pt) 2011-04-22 2012-04-23 método e sistema para analisar características de tecido, e, kit

Country Status (8)

Country Link
US (5) US20120269419A1 (https=)
EP (4) EP2700042B1 (https=)
JP (4) JP6143743B2 (https=)
BR (4) BR112013027122A2 (https=)
CA (4) CA2833804A1 (https=)
RU (3) RU2013145162A (https=)
SG (4) SG194588A1 (https=)
WO (4) WO2012143558A2 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201111594D0 (en) * 2011-07-06 2011-08-24 Equateq Ltd New improved process
EP2929420B1 (en) * 2012-12-06 2022-03-02 Leica Microsystems CMS GmbH Systems and methods for split screen display of a biological specimen and for capturing records thereof
US9488639B2 (en) * 2013-02-25 2016-11-08 Flagship Biosciences, Inc. Cell-based tissue analysis
US8995740B2 (en) * 2013-04-17 2015-03-31 General Electric Company System and method for multiplexed biomarker quantitation using single cell segmentation on sequentially stained tissue
CA2916520A1 (en) * 2013-07-03 2015-01-08 Coyne Ip Holdings, Llc Methods for predicting responses to chemical or biologic substances
US9322051B2 (en) 2013-10-07 2016-04-26 General Electric Company Probing of biological samples
US9298968B1 (en) * 2014-09-12 2016-03-29 Flagship Biosciences, Inc. Digital image analysis of inflammatory cells and mediators of inflammation
JP6791598B2 (ja) 2015-01-22 2020-11-25 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 異なる細胞サブセットの比率の決定方法およびシステム
US9953133B2 (en) 2015-06-03 2018-04-24 General Electric Company Biological data annotation and visualization
US10672505B2 (en) 2015-06-03 2020-06-02 General Electric Company Biological data annotation and visualization
WO2017109860A1 (ja) * 2015-12-22 2017-06-29 株式会社ニコン 画像処理装置
US20180032681A1 (en) * 2016-07-29 2018-02-01 General Electric Company Biological feature analysis technique
CN110192140A (zh) * 2016-11-16 2019-08-30 华盛顿大学 用于循环荧光成像的系统和方法
US11042551B2 (en) * 2016-12-02 2021-06-22 Fair Isaac Corporation Fast automatic explanation of scored observations
US11436719B2 (en) 2017-02-16 2022-09-06 Kyoto University Cell evaluation method, cell evaluation device, and recording medium storing cell evaluation program
US10242473B2 (en) * 2017-03-22 2019-03-26 Sas Institute Inc. Computer system to generate scalable plots using clustering
US10535434B2 (en) 2017-04-28 2020-01-14 4D Path Inc. Apparatus, systems, and methods for rapid cancer detection
KR101990430B1 (ko) * 2017-06-22 2019-06-18 한국과학기술원 암의 재발 예후 예측을 위한 바이오마커 발굴 시스템 및 방법
US12249401B2 (en) 2017-07-21 2025-03-11 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for analyzing mixed cell populations
US10706328B2 (en) 2018-05-07 2020-07-07 Google Llc Focus-weighted, machine learning disease classifier error prediction for microscope slide images
US10971255B2 (en) * 2018-09-14 2021-04-06 Zasti Inc. Multimodal learning framework for analysis of clinical trials
US11101043B2 (en) 2018-09-24 2021-08-24 Zasti Inc. Hybrid analysis framework for prediction of outcomes in clinical trials
US20220015714A1 (en) * 2018-11-29 2022-01-20 Somalogic, Inc. Methods For Determining Disease Risk Combining Downsampling of Class-Imbalanced Sets With Survival Analysis
US11128667B2 (en) * 2018-11-29 2021-09-21 Rapid7, Inc. Cluster detection and elimination in security environments
CN113158982A (zh) * 2021-05-17 2021-07-23 广东中卡云计算有限公司 一种半介入式的目标关键点标注方法
WO2023033056A1 (ja) * 2021-09-01 2023-03-09 イミュニティリサーチ株式会社 細胞集団同定システム、方法、およびプログラム
IT202200001817A1 (it) 2022-02-02 2023-08-02 Aizoon S R L Procedimento per la prognosi di una malattia in seguito ad un trattamento terapeutico, relativo sistema e prodotto informatico
IT202200005861A1 (it) 2022-03-24 2023-09-24 Aizoon S R L Procedimento per stimare una variabile di interesse associata ad una data malattia in funzione di una pluralità di diversi dati omici, relativo dispositivo e prodotto informatico
CA3207405A1 (en) 2022-07-25 2024-01-25 Aizoon S.r.l. Method for providing a clinical decision support, corresponding system for providing a clinical decision support, and computer program product
WO2025258375A1 (ja) * 2024-06-12 2025-12-18 ソニーグループ株式会社 情報処理方法及び情報処理システム

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6463438B1 (en) * 1994-06-03 2002-10-08 Urocor, Inc. Neural network for cell image analysis for identification of abnormal cells
US5740269A (en) * 1994-09-20 1998-04-14 Neopath, Inc. Method and apparatus for robust biological specimen classification
US6996549B2 (en) * 1998-05-01 2006-02-07 Health Discovery Corporation Computer-aided image analysis
US6282305B1 (en) * 1998-06-05 2001-08-28 Arch Development Corporation Method and system for the computerized assessment of breast cancer risk
US6337472B1 (en) * 1998-10-19 2002-01-08 The University Of Texas System Board Of Regents Light imaging microscope having spatially resolved images
JP2005503760A (ja) * 2001-01-24 2005-02-10 プロテイン デザイン ラブス， インコーポレイテッド 乳癌の診断方法、組成物および乳癌のモジュレーターのスクリーニング方法
WO2004013658A2 (en) * 2002-07-30 2004-02-12 Deutsches Krebsforschungszentrum Method and apparatus for multiple labeling detection and evaluation of a plurality of particles
US20040121413A1 (en) * 2002-12-20 2004-06-24 Aebersold Rudolf H. Androgen-regulated genes and uses for diagnosis, prognosis and treatment of prostate neoplastic conditions
US20050265588A1 (en) * 2004-02-03 2005-12-01 Bioimagene, Inc. Method and system for digital image based flourescent in situ hybridization (FISH) analysis
WO2006113747A2 (en) * 2005-04-19 2006-10-26 Prediction Sciences Llc Diagnostic markers of breast cancer treatment and progression and methods of use thereof
US8041090B2 (en) * 2005-09-10 2011-10-18 Ge Healthcare Uk Limited Method of, and apparatus and computer software for, performing image processing
US7933435B2 (en) * 2005-11-21 2011-04-26 Vala Sciences, Inc. System, method, and kit for processing a magnified image of biological material to identify components of a biological object
CN101484806A (zh) * 2006-05-17 2009-07-15 协乐民公司 一种对组织进行自动分析的方法
US7741045B2 (en) * 2006-11-16 2010-06-22 General Electric Company Sequential analysis of biological samples
US8019134B2 (en) * 2006-11-16 2011-09-13 Definiens Ag Automatic image analysis and quantification for fluorescence in situ hybridization
EP2132327A2 (en) * 2007-03-27 2009-12-16 Rosetta Genomics Ltd Gene expression signature for classification of cancers
CA2683134A1 (en) * 2007-05-07 2008-11-13 Ge Healthcare Bio-Sciences Corp. System and method for the automated analysis of cellular assays and tissues
WO2008143849A2 (en) * 2007-05-14 2008-11-27 Historx, Inc. Compartment segregation by pixel characterization using image data clustering
EP2195467B1 (en) * 2007-09-06 2016-12-14 bioTheranostics, Inc. Tumor grading and cancer prognosis in breast cancer
US9858389B2 (en) * 2008-07-25 2018-01-02 Fundação D. Anna De Sommer Champalimaud E Dr. Carlos Montez Champalimaud Method and system for determining the risk of occurrence of prostate cancer
US9779213B2 (en) * 2008-07-25 2017-10-03 Fundacao D. Anna Sommer Champalimaud E Dr. Carlos Montez Champalimaud System for evaluating a pathological stage of prostate cancer
US8320655B2 (en) * 2009-10-16 2012-11-27 General Electric Company Process and system for analyzing the expression of biomarkers in cells
US20110091081A1 (en) * 2009-10-16 2011-04-21 General Electric Company Method and system for analyzing the expression of biomarkers in cells in situ in their tissue of origin
WO2011087778A1 (en) * 2009-12-22 2011-07-21 The Children's Hospital Of Philadelphia Automated quantitative multidimensional volumetric analysis and visualization

Also Published As

Publication number Publication date
WO2012143558A3 (en) 2012-12-20
JP6163152B2 (ja) 2017-07-12
SG194588A1 (en) 2013-12-30
EP2700037A2 (en) 2014-02-26
EP2700038B1 (en) 2021-04-21
RU2013145154A (ru) 2015-05-27
JP2014516413A (ja) 2014-07-10
RU2013145162A (ru) 2015-05-27
JP2014517954A (ja) 2014-07-24
WO2012143556A2 (en) 2012-10-26
WO2012143558A2 (en) 2012-10-26
US20140185905A1 (en) 2014-07-03
EP2700042A2 (en) 2014-02-26
WO2012143561A2 (en) 2012-10-26
BR112013027123A2 (pt) 2017-01-10
JP6063447B2 (ja) 2017-01-18
EP2700038A2 (en) 2014-02-26
EP2700036A2 (en) 2014-02-26
US20120270752A1 (en) 2012-10-25
WO2012143561A3 (en) 2013-05-23
CA2833295A1 (en) 2012-10-26
JP2014521926A (ja) 2014-08-28
CA2833428A1 (en) 2012-10-26
WO2012143562A3 (en) 2013-02-28
BR112013027125A2 (pt) 2017-01-10
EP2700042B1 (en) 2021-03-17
US20120269419A1 (en) 2012-10-25
JP2014521925A (ja) 2014-08-28
US20120269418A1 (en) 2012-10-25
CA2833497A1 (en) 2012-10-26
SG194592A1 (en) 2013-12-30
BR112013027124A2 (pt) 2017-01-10
SG194594A1 (en) 2013-12-30
US20120271553A1 (en) 2012-10-25
WO2012143556A3 (en) 2013-05-30
CA2833804A1 (en) 2012-10-26
JP6063446B2 (ja) 2017-01-18
JP6143743B2 (ja) 2017-06-07
RU2013145151A (ru) 2015-05-27
WO2012143562A2 (en) 2012-10-26
SG194590A1 (en) 2013-12-30

Similar Documents

Publication Publication Date Title
BR112013027122A2 (pt) método e sistema para analisar características de tecido, e, kit
JP2014517954A5 (https=)
BR112016010322A2 (pt) Método computadorizado de avaliação de risco de câncer de pulmão, meio legível por computador, sistema de avaliação de câncer de pulmão, e método de geração de um classificador para avaliação de risco de câncer de pulmão
BR112014030245A2 (pt) métodos e aparelhos para monitorar apresentações de mídia
MX355020B (es) Biomarcadores de cancer de pulmon y usos de los mismos.
NZ621733A (en) Lung cancer biomarkers and uses thereof
Etheridge et al. The integrin-adhesome is required to maintain muscle structure, mitochondrial ATP production, and movement forces in Caenorhabditis elegans
AR095363A1 (es) Biomarcadores y métodos para el tratamiento de condiciones relacionadas con pd-1 y pd-l1
BR112014025246A8 (pt) método para classificação de uma amostra em uma de pelo menos duas classes com base em dados espectrais, método para criar um banco de dados para uso na classificação de uma amostra em uma de pelo menos duas classes com base em dados espectrais, programa de computador, meio de armazenagem de dados, e sistema para classificar uma amostra com base em dados espectrais
BR112013003391B8 (pt) Método para diagnosticar câncer pancreático em um indivíduo
BR112015017767A2 (pt) sistema para detectar estágios do sono de um indivíduo, método para detectar estágios do sono de um indivíduo, e, sistema configurado para detectar estágios do sono de um indivíduo
BR112015031639A2 (pt) integração alvo
MX2018009304A (es) Metodos de diagnostico y pronostico para episodios y enfermedades cardiovasculares.
BR112013003751A2 (pt) sistema e método para estimar características direcionais com base nas medidas do momento de flexão
MX364249B (es) Sistemas y métodos de predicción de permeabilidad utilizando análisis discriminante cuadrático.
BR112014029233A8 (pt) método para diagnosticar se um indivíduo grávido não está em risco, usos de pelo menos um dos biomarcadores sfit-1, endoglina e pigf, dispositivo, kit, método de gestão de um indivíduo, sistema e método para estabelecer um auxílio
EA201591045A1 (ru) Способ и система идентификации дефектов стекла
BR102012002812A8 (pt) método para determinar a influência de uma variável em um fenômeno
Keller et al. Competitive learning suggests circulating miRNA profiles for cancers decades prior to diagnosis
BR112012024175A2 (pt) hbf e a1m como marcadores de estágio precoce para preeclampsia
BR112017003608A2 (pt) ?método para a análise comparativa do nível de expressão de mirna(s) alvo(s), dispositivo de análise da expressão de mirna, programa(s) para uma análise comparativa do(s) nível(eis) de expressão de mirna(s), meio de gravação legível por computador e chip para análise da expressão de mirna?
WO2012153964A3 (ko) 지질 프로파일을 이용한 비소세포성 폐암의 조직학적 분류를 위한 정보를 제공하는 방법
BR112022006352A2 (pt) Método e sistema para submeter uma pluralidade de micropoços contendo células a um ensaio de alto conteúdo, e, programa de computador
LV et al. The diagnostic and prognostic effect of serum copeptin level in patients with acute pancreatitis
Yujie et al. Expressions and clinical significances of DLC-1 and ROCKⅠin non-small cell lung cancer

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]